Cargando…
Live-Birth Outcomes and Congenital Malformations After Progestin-Primed Ovarian Stimulation in Maternal Endometriosis
PURPOSE: In patients who had advanced endometriosis, we use different protocols including GnRH agonist, GnRH antagonist and progestin-primed ovarian stimulation (PPOS) protocols to assess live-birth congenital malformations delivered after in vitro fertilization (IVF) and vitrified embryo transfer c...
Autores principales: | Liang, Zhou, Wang, Yun, Kuang, Yanping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735717/ https://www.ncbi.nlm.nih.gov/pubmed/33328724 http://dx.doi.org/10.2147/DDDT.S263138 |
Ejemplares similares
-
Neonatal outcomes and congenital malformations in children born after progestin-primed ovarian stimulation protocol
por: Li, Danjun, et al.
Publicado: (2022) -
Comparison of neonatal outcomes and live-birth defects after progestin-primed ovarian stimulation versus conventional ovarian stimulation for in vitro fertilization: A large retrospective cohort study
por: Wang, Ningling, et al.
Publicado: (2018) -
Neonatal outcomes and congenital malformations in children born after dydrogesterone application in progestin-primed ovarian stimulation protocol for IVF: a retrospective cohort study
por: Huang, Jialyu, et al.
Publicado: (2019) -
Progestin-primed milder stimulation with clomiphene citrate yields fewer oocytes and suboptimal pregnancy outcomes compared with the standard progestin-primed ovarian stimulation in infertile women with polycystic ovarian syndrome
por: Ye, Hongjuan, et al.
Publicado: (2018) -
Anti-müllerian Hormone for the Prediction of Ovarian Response in Progestin-Primed Ovarian Stimulation Protocol for IVF
por: Huang, Jialyu, et al.
Publicado: (2019)